Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients. [electronic resource]
Producer: 20191203Description: e13424 p. digitalISSN:- 1399-0012
- Adolescent
- Adult
- Black or African American -- genetics
- Aged
- Aged, 80 and over
- Cytochrome P-450 CYP3A -- genetics
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Genotype
- Graft Rejection -- drug therapy
- Graft Survival -- drug effects
- Humans
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Kidney Failure, Chronic -- surgery
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Minnesota -- epidemiology
- Postoperative Complications
- Prognosis
- Prospective Studies
- Risk Factors
- Tacrolimus -- therapeutic use
- White People -- genetics
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.